ID    AVR/I/SSAP56
ET    Clinical
PN    Smp24GVG
PL    26 [Note: any special compound, if present in sequence, is not considered in length]
SR    Not available
SO    Scorpio maurus palmatus
TX    Animalia (Scorpion)
VL    Experimentally validated
XX
TO    VISA MU50 (clinical isolate from Sheffield Hallam University)
IC    MIC = 32 microG/ML
TH    The addition of a Gly-Val-Gly hinge to Smp24, resulting in Smp24GVG, did not alter its hemolytic activity or significantly change its cytotoxicity in HepG2 cells compared to the parent peptide.
XR    PubMed: 27019370
XR    RCSB PDB/PDBsum/PDBe/PDBj/PDBe-KB/MMDB: Not available 
XR    UniProt: Not available
XR    DrugBank: Not available
XX
SQ    SEQUENCE  
      IWSFLIKAAT KLLGVGSLFG GG-KKDS 
//

